Purchase any Semaglutide or Tirzepatide program and receive an additional dose of the same product, plus 1 complimentary MIC/L-Carnitine injection.
Terms and conditions: Additional free doses of Semaglutide or Tirzepatide will be for the same product purchased and will be applied upon completion of the corresponding program. These are personal, non-transferable, non-refundable, and cannot be exchanged for cash or other products. If the patient switches products or treatments before completing the program, the corresponding additional free doses will be forfeited. All administration is subject to medical evaluation and authorization. Offers cannot be combined. Offer valid from October 1 to October 31, 2026.
Tirzepatide is an advanced medication that combines appetite control and metabolic support to deliver effective, sustainable weight loss results. This FDA-approved prescription is indicated for adults with obesity or overweight who also have at least one weight-related condition (such as hypertension, type 2 diabetes, or high cholesterol).
Tirzepatide activates both the GIP and GLP-1 receptors—natural incretin hormones that influence digestion and the central nervous system. This dual action helps regulate fat metabolism, reduce appetite, and support blood glucose balance.
New patients begin with the lowest dose, gradually increasing under medical supervision to reduce possible side effects. Administration is subcutaneous, once per week.
Tirzepatide should not be used alongside other GLP-1 medications or weight-loss supplements. Consult our medical team to determine if Tirzepatide is appropriate for you.
Key Benefits:
